Legend Biotech (LEGN) Return on Assets (2020 - 2025)
Legend Biotech (LEGN) reported Return on Assets of 0.0% for Q4 2025, little changed on a YoY basis from 0.0% in Q4 2024, and down 10.22% quarter-over-quarter from 0.0% in Q3 2025.
Legend Biotech (LEGN) Return on Assets (2020 - 2025) Analysis & Trends
Legend Biotech has reported Return on Assets for 6 years, with the latest figure at 0.0% in Q4 2025.
- For the quarter ending Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Assets for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
- The five-year high for Return on Assets was 0.0% in Q2 2021, with the low at 0.0% in Q1 2023.
- Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2025.
- The largest YoY upside for Return on Assets was 0 bps in 2021 against a maximum downside of 0 bps in 2021.
- Legend Biotech's Return on Assets stood at 0.0% in 2021, then increased by 1 bps to 0.0% in 2022, then advanced by 9 bps to 0.0% in 2023, then soared by 71 bps to 0.0% in 2024, then plunged by 63 bps to 0.0% in 2025.
- The last three Return on Assets figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -0.01% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.01% |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |